Sangoma Technologies Corp Stock Price, News & Analysis

Sangoma Technologies (TSX: STC; Nasdaq: SANG) announced that two of its executives have been recognized on CRN's 2025 Women of the Channel list. Susan Leveritt, Channel Chief and VP of US Sales, and Karla Roarty, Channel Sales Director, were honored for their contributions to the IT channel ecosystem.

Leveritt, with over 20 years of experience, is credited with transforming Sangoma's partner strategy and launching the Pinnacle Partner Program. Roarty brings 20+ years of technology industry experience, specializing in partner growth and enablement. The recognition will be featured in CRN Magazine's June issue and on CRN.com starting May 12.

Sangoma Technologies (TSX: STC; Nasdaq: SANG) reported its Q3 FY2025 results, showing mixed performance. Revenue came in at $58.1 million, down 2% from Q2 FY2025, though core platform and on-premises revenues increased for the second consecutive quarter. The company posted a net loss of $1.4 million ($0.04 per share). Notable achievements include Adjusted EBITDA of $9.8 million (17% margin), industry-leading quarterly churn below 1%, and strong free cash flow of $8.4 million ($0.25 per share). The company successfully reduced its total debt to $53 million, surpassing its FY2025 target ahead of schedule. Sangoma reaffirmed and narrowed its FY2025 revenue guidance to $235-238 million and maintained Adjusted EBITDA guidance of $40-42 million.

Sangoma Technologies, a leading provider of Communications as a Service (CaaS) solutions, has scheduled its third quarter fiscal 2025 financial results announcement. The company, listed on both TSX (STC) and Nasdaq (SANG), will release its results after market close on Thursday, May 8, 2025.

A conference call will follow the release at 5:30 PM Eastern Time on the same day. Investors and interested parties can join using the dial-in number 1-833-752-3740 (International: +1-647-846-8617). Participants should dial in 5 minutes before the scheduled start time and request to join the Sangoma Technologies call.

Sangoma uniquely positions itself by offering businesses flexible communication solutions through three delivery models: on-premises, cloud-based, or hybrid Communications as a Service.

Sangoma Technologies (TSX: STC; Nasdaq: SANG), a provider of comprehensive Communications as a Service solutions, has announced its participation in the Planet MicroCap Showcase: VEGAS 2025. The event will take place on Wednesday, April 23, 2025 at 8:00 AM PDT.

CEO Charles Salameh will lead the presentation and conduct a Q&A session. The event will be held at the Paris Hotel & Casino in Las Vegas, offering both in-person and virtual attendance options through a live webcast. Investors can schedule one-on-one meetings with Sangoma representatives during the conference.

The company, which offers businesses flexible options including on-premises, cloud-based, or hybrid communications solutions, will make its presentation available on the conference platform for those unable to attend the live session.

Sangoma Technologies (TSX: STC; Nasdaq: SANG) has exceeded its FY25 debt reduction targets ahead of schedule and announced the launch of a Normal Course Issuer Bid (NCIB). The company has issued an irrevocable notice for an additional $2.9 million debt repayment, bringing Q3 total repayments to $7.3 million.

The full repayment of Term Loan 1 has reduced total debt to approximately $53 million at Q3 end, surpassing the original FY25 target of $55-$60 million. The NCIB program will allow Sangoma to purchase up to 1,679,720 shares (5% of outstanding shares) for cancellation between March 27, 2025, and March 26, 2026.

Daily purchases will be to 9,429 shares, with block purchase exceptions available weekly. The company will fund the share buyback through surplus operational cash flow.

Sangoma Technologies (TSX: STC; Nasdaq: SANG) released its Q2 FY2025 results, showing mixed performance. Net cash from operations increased 29.7% year-over-year, exceeding 100% of Adjusted EBITDA for the fourth consecutive quarter. Total revenue was $59.1 million, down 1.7% from Q1 FY2025, primarily due to decreased low-margin third-party product resales.

Key metrics include gross profit of $40.5 million (68.5% margin), Adjusted EBITDA of $10.1 million (17.1% of revenue), and improved churn below 1.0%. Operating expenses decreased 7.3% year-over-year to $41.3 million. Net loss narrowed to $1.9 million from $3.2 million in Q2 FY2024.

The company revised its FY2025 guidance, lowering revenue expectations to $235-240 million from $250-260 million, while maintaining an Adjusted EBITDA target of at least 17% of revenue ($40-42 million).

Sangoma Technologies (TSX: STC; Nasdaq: SANG) has unveiled its proprietary AI platform, Sangoma GenAI, introducing several AI-powered innovations in business communications. The platform includes an Enhanced Conversational IVR for streamlining customer interactions, a Patient Relationship Management System developed with Sphinx Medical's CallMyDoc® for healthcare automation, and Sangoma Scribe for voice record transcription and analysis.

The company has also enhanced its Sangoma CX® contact center solution with GoogleFlow-powered chatbots and AI Assist features to improve agent productivity. These innovations aim to optimize operations, customer engagement, and team collaboration while providing affordable enterprise-grade solutions. Sangoma continues its investment in open source projects Asterisk and FreePBX, with plans to showcase AI integration at the upcoming 20th annual AstriCon conference in Fort Lauderdale.

Sangoma Technologies (TSX: STC; Nasdaq: SANG), a provider of cloud-based Communications as a Service solutions, has announced it will release its second quarter fiscal year 2025 financial results after market close on February 5, 2025. The company will host a conference call the same day at 5:30 PM Eastern Time to discuss the results. Investors can join the call using the dial-in number 1-844-763-8274 (International: +1-647-484-8814) and are requested to dial in 5 minutes before the scheduled start time.

Sangoma Technologies (TSX: STC; Nasdaq: SANG) has partnered with Sphinx Medical Technologies to launch a new Patient Relationship Management (PRM) system, integrating Sangoma's unified communications platform with Sphinx's CallMyDoc® AI-powered IVR system. The solution offers 99.999% uptime and seamlessly integrates with Electronic Health Records (EHR) systems while maintaining HIPAA compliance.

The system leverages CallMyDoc®'s 20 million patient call history and provides features including 24/7 virtual consultations, multilingual support, automated follow-up care, and real-time patient record access. It significantly improves efficiency by reducing call time by 10x and automating tasks like prescription refills and appointment scheduling. The solution includes automated appointment reminders, integrated online booking, and advanced call routing capabilities.